Nedocromil sodium: a review of clinical studies
- PMID: 2553034
Nedocromil sodium: a review of clinical studies
Abstract
Nedocromil sodium is a new compound for the long-term treatment of bronchial asthma. Its effect has been studied in prevention of bronchospasm induced by a variety of stimuli showing a broader spectrum of activity than SCG. Its clinical efficacy has been demonstrated in a number of trials involving patients regardless of asthma type.